Matthew J D'Onofrio

CIK 1578770 · Chief Executive Officer · last filed 2025-12-17

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

25

Lifetime Open-Market Net

-$134.1K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Evoke Pharma Inc (EVOK) Delisted Chief Executive Officer 0 $11.00 $0 -$134.1K 13 2025-12-17
Evoke Pharma Inc (OMED) Delisted Exec VP, Chief Bus. Officer 238,759 $0 12 2019-02-08

Recent Filings · Page 3 of 3

25 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2016-02-05 Evoke Pharma Inc (OMED) Delisted Mixed $0 EDGAR
2016-01-29 Evoke Pharma Inc (OMED) Delisted Grant (A) $0 EDGAR
2015-03-09 Evoke Pharma Inc (OMED) Delisted Grant (A) $0 EDGAR
2015-03-02 Evoke Pharma Inc (OMED) Delisted Other (J) +6,671 $31.7K EDGAR
2013-12-03 Evoke Pharma Inc (OMED) Delisted Grant (A) $0 EDGAR
Showing 2125 of 25
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.